CHONDROSULPHATASE AND USE THEREOF

Abstract

Provided are chondrosulfatase and a use thereof, belonging to the technical field of biological engineering. Chondrosulfatase is screened and identified from the natural world, the maximum similarity between its amino acid sequence and that of the chondrosulfatase reported by NCBI being 85%; then the expression in Escherichia coli and Bacillus subtilis is optimized, achieving the high-efficiency biosynthesis of chondrosulfatase having high enzymatic activity, the maximum enzyme activity being 11976.5 U/L; furthermore, the entire process and post-processing are simpler. The invention has potentially broad value in application in the preparation of products containing low molecular-weight chondroitin sulfate in the fields of medicine, cosmetics, and biology, lays the foundation for efficient fermentation of a microbial system to produce a chondrosulfatase having high enzyme activity, and is suitable for industrialized production applications.

Claims

1. A chondrosulphatase, wherein an amino acid sequence is shown in SEQ ID No. 1.

2. (canceled)

3. (canceled)

4. (canceled)

5. (canceled)

6. (canceled)

7. (canceled)

8. (canceled)

9. (canceled)

10. A use of the chondrosulphatase according to claim 1 in a preparation of products containing low molecular weight chondroitin sulfate in fields of medicine, cosmetics and biology.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0014] FIG. 1 shows the schematic diagram of the construction of vector for optimized expression of ChSase in E. coli.

[0015] FIG. 2 shows the schematic diagram of the construction of vector for optimized expression of ChSase in B. subtilis.

[0016] FIG. 3 shows the enzyme activity of optimized expression of ChSase in E. coli and B. subtilis cultured in shake flask for 50 h.

DESCRIPTION OF THE EMBODIMENTS

[0017] Amino acid sequence information involved in the examples:

[0018] SEQ ID No. 1 is the amino acid sequence of a novel ChSase screened and identified from the nature of the invention.

Example 1: Screening and Identification of ChSase

[0019] Collected soil samples, sewage or sludge from coastal areas, river banks, farmers' markets, slaughterhouses and dining halls. Extracted suitable amount of soil samples with physiological saline. The enrichment cultured samples were gradient diluted and spreaded on the screening plate, then cultured at 37° C. for 3 days. The colonies with transparent circles were selected for secondary screening. The selected culture medium (g/L) was: chondroitin sulfate 4.5, ammonium chloride 2.5, sodium chloride 0.95, magnesium sulfate 1.0, dipotassium hydrogen phosphate 1.0, agar 20.0, bovine serum albumin 5.0, pH 7.0. Compared and selected the colony with the largest ratio of transparent circle to strain diameter in the re-screening plate, and inoculated the colony into the liquid fermentation medium for culture. The genome of the flora was extracted for metagenomic sequencing, and the sequence with the highest possibility of ChSase was analyzed and screened. The amino acid sequence with the highest probability of ChSase was compared with the ChSase reported by NCBI. The final result was that the highest similarity between this enzyme and the ChSase reported by NCBI was 85%. The sequence was artificially synthesized and expressed in E. coli and B. subtilis, and the results of further identification proved the enzyme was ChSase.

Example 2: Optimized Expression of ChSase in E. coli and B. subtilis

[0020] Construction of Expression System:

[0021] The fragment CS DNA was amplified by PCR with the primer CS(pBRSF)-F/CS(pBRSF)-R which used artificially synthesized CS DNA as the template. Recombinant plasmid pBRSFDuet-1-CS was constructed by splicing the CS DNA PCR product and skeleton plasmid pBRSFDuet-1 which used the primer pBRSF-F/pBRSF-R.

[0022] The fragment CS DNA was amplified by PCR with the primer CS(pHT)-F/CS(pHT)-R which used artificially synthesized CS DNA as the template. Recombinant plasmid pHT01-CS was constructed by splicing the CS DNA PCR product and skeleton plasmid pHT01 which used the primer pHT01-F/pHT01-R.

[0023] Construction of Recombinant Bacteria:

[0024] The recombinant plasmid pBRSFDuet-1-CS was transferred into E. coli MG1655, E. coli DHSa, E. coli W3110, and E. coli BL21 to construct the recombinant strain CSmg, CSdh, CSw300, and CSbl, respectively.

[0025] The recombinant plasmid pHT01-CS was transferred into B. subtilis 168, B. subtilis WB600, and B. subtilis WB800 to construct the recombinant strain CS168, CS600, and CS800, respectively.

[0026] The construction of E. coli vector optimized for ChSase expression is shown in FIG. 1; the construction of B. subtilis vector optimized for ChSase expression is shown in FIG. 2.

[0027] The primer information (5′-3′) is as follows:

TABLE-US-00001 pBRSF-F AAGCTTTCGCCGTTGCCCTAACATATGGCAGATCTCA ATTGGATATCGGCCGG pBRSF-R GGTACCCATGTGTACATTCCTCTCTTTATATCTCCTT CTTATACTTAACTAATATACT CS(pBRSF)-F TAAGTATAAGAAGGAGATATAAAGAGAGGAATGTACA CATGGGTACCTCTAATCCTGCC CS(pBRSF)-R CCGGCCGATATCCAATTGAGATCTGCCATATGTTAGG GCAACGGCGAAAGCTT pHT01-F AAGCTTTCGCCGTTGCCCTAAGGATCCTCTAGAGTCG ACGTCCCCGGGGCAG pHT01-R TACCCATGTGTACATTCCTCTCTTAATTGGGAATTGT TATCCGCTCACAATTCCACAAT CS(pHT)-F AGCGGATAACAATTCCCAATTAAGAGAGGAATGTACA CATGGGTACCTCTAATCCTGCC CS(pHT)-R CTGCCCCGGGGACGTCGACTCTAGAGGATCCTTAGGG CAACGGCGAAAGCTT

[0028] Monoclone of seven recombinant strains and the control strains (pBRSFDuet-1 empty plasmid and pHT01 empty plasmid were transformed by E. coli and B. subtilis, respectively) were inoculated into 5 mL LB culture containing appropriate antibiotics (the final concentration of 50 μg/mL kanamycin for E. coli and the final concentration of 25 μg/mL chloramphenicol for B. subtilis). The seed inoculum was cultured at 37° C. at 200 rpm for 10 h, and transferred to a 250 mL flask with a liquid volume of 25 mL according to the inoculation amount of 10%, and the medium was the fermentation medium. 1.5 mmol/L IPTG and appropriate antibiotics (the final concentration of 50 μg/mL kanamycin for E. coli and the final concentration of 25 μg/mL chloramphenicol for B. subtilis) were added as required. The cultures were incubated at 37° C. and 220 rpm. After an incubation time of 50 h, the enzyme activity was determined. The method of the ChSases enzyme activity was as follows: sonicating the fermentation broth to disrupt the cells, and the supernatant was harvested as crude enzyme by centrifugation at 12000 rpm and 4° C. for 20 min. The crude enzyme solution was purified by MBP column and eluted with 10 mM maltose. 40 μL of diluted enzyme solution was added to 960 μL of substrate solution (2 g/L of C4S dissolved in 20 mM Tris-HCl). The initial reaction rate within 1 min was determined by kinetic-based enzyme activity determination method. Definition of the enzyme activity: the amount of enzyme required to consume 1 micromole of substrate per unit time is defined as one unit of enzyme activity. The results of enzyme activity in FIG. 3 showed that all of the recombinant strains could realize the high-efficiency biosynthesis of high activity ChSase, and the highest ChSase activity was obtained from CSdh as 11976.5 U/L.

[0029] Although the present invention has been disclosed as above with preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention should be defined by the claims.